Bansal Nitin, Goyal Pankaj, Basu Dharmishtha, Batra Ullas, Sachdeva Neelam, Joga Srujana, Jain Arpit, Doval D C
Rajiv Gandhi Cancer Institute, New Delhi, India.
Indian J Med Microbiol. 2023 Sep-Oct;45:100383. doi: 10.1016/j.ijmmb.2023.100383. Epub 2023 May 23.
Improving basic infection control (IC) practices, diagnostics and anti-microbial stewardship (AMS) are key tools to handle antimicrobial resistance (AMR).
This is a retrospective study done over 6 years (2016-2021) in an oncology centre in North India with many on-going interventions to improve IC practices, diagnostics and AMS. This study looked into AMR patterns from clinical isolates, rates of hospital acquired infections (HAI) and clinical outcomes.
Over all, 98,915 samples were sent for culture from 158,191 admitted patients. Most commonly isolated organism was E. coli (n = 6951; 30.1%) followed by Klebsiella pneumoniae (n = 5801; 25.1%) and Pseudomonas aeroginosa (n = 3041; 13.1%). VRE (Vancomycin resistant Enterococcus) rates fell down from 43.5% in Jan-June 2016 to 12.2% in July-Dec 2021, same was seen in CR (carbapenem resistant) Pseudomonas (23.0%-20.6%, CR Acinetobacter (66.6%-17.02%) and CR E. coli (21.6%-19.4%) over the same study period. Rate of isolation of Candida spp. from non-sterile sites also showed reduction (1.68 per 100 patients to 0.65 per 100 patients). Incidence of health care associated infections also fell from 2.3 to 1.19 per 1000 line days for CLABSI, 2.28 to 1.88 per 1000 catheter days for CAUTI. There was no change in overall mortality rates across the study period.
This study emphasizes the point that improving compliance to standard IC recommendations and improving diagnostics can help in reducing the burden of antimicrobial resistance.
改进基本感染控制(IC)措施、诊断方法和抗菌药物管理(AMS)是应对抗菌药物耐药性(AMR)的关键手段。
这是一项在印度北部一家肿瘤中心进行的为期6年(2016 - 2021年)的回顾性研究,期间采取了多项持续干预措施以改进感染控制措施、诊断方法和抗菌药物管理。本研究调查了临床分离株的AMR模式、医院获得性感染(HAI)发生率及临床结局。
总体而言,从158,191名住院患者中送检了98,915份样本进行培养。最常分离出的病原体是大肠埃希菌(n = 6951;30.1%),其次是肺炎克雷伯菌(n = 5801;25.1%)和铜绿假单胞菌(n = 3041;13.1%)。耐万古霉素肠球菌(VRE)的比率从2016年1月至6月的43.5%降至2021年7月至12月的12.2%,在同一研究期间,耐碳青霉烯类铜绿假单胞菌(23.0% - 20.6%)、耐碳青霉烯类不动杆菌(66.6% - 17.02%)和耐碳青霉烯类大肠埃希菌(21.6% - 19.4%)也出现了同样的情况。从非无菌部位分离出念珠菌属的比率也有所下降(从每100名患者1.68例降至每100名患者0.65例)。医疗保健相关感染的发生率也有所下降,中心静脉导管相关血流感染(CLABSI)从每1000个导管日2.3例降至1.19例,导尿管相关尿路感染(CAUTI)从每1000个导管日2.28例降至1.88例。在整个研究期间,总体死亡率没有变化。
本研究强调了提高对标准感染控制建议的依从性和改进诊断方法有助于减轻抗菌药物耐药性负担这一观点。